is questioning Abbott Laboratories' business practices after ... shortage that is leaving Americans scrambling to find the product.

Abbott Laboratories and a unit of Reckitt Benckiser Group Plc were cleared by a jury over claims they hid risks their ...

Abbott Laboratories showcases robust financial performance with a notable increase in net earnings. Strategic acquisitions ...

We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...

Abbott Laboratories (NYSE:ABT), together with its subsidiaries, discovers, develops, manufactures and sells health care ...

Parents allege that the specialized, cow’s-milk based products for preterm infants caused their ... totaling $495 million against Abbott Laboratories and $60 million against Mead Johnson. The third ...

A St. Louis jury handed Abbott Laboratories a win Thursday, deciding that Abbott, another company and a hospital were not ...

Marie Thibault, an analyst from BTIG, reiterated the Buy rating on Abbott Laboratories (ABT – Research Report). The associated price ...

Citi analyst Joanne Wuensch maintained a Hold rating on Establishment Labs Holdings (ESTA – Research Report) today and set a price target ...

Shares of Abbott Laboratories are rising and those of Reckitt Benckiser are gaining in London trading Friday, a day after a ...

In closing arguments on Wednesday, plaintiff's lawyer Timothy Cronin asked jurors for $6 billion in punitive damages.

Shares of Abbott Laboratories and Reckitt Benckiser rose Friday after the companies won a victory in litigation over the safety of some of their baby-formula products. Abbott shares rose 4% in early ...